Literature DB >> 31475347

Corrigendum.

.   

Abstract

Year:  2019        PMID： 31475347      PMCID： PMC8097587          DOI： 10.1111/bjd.18352

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  1 in total

1.  Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Authors:  Z Z N Yiu; D M Ashcroft; I Evans; K McElhone; M Lunt; C H Smith; S Walton; R Murphy; N J Reynolds; A D Ormerod; C E M Griffiths; R B Warren
Journal:  Br J Dermatol       Date:  2018-10-21       Impact factor: 9.302
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.